A detailed history of Slocum, Gordon & CO LLP transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Slocum, Gordon & CO LLP holds 424 shares of TMO stock, worth $240,475. This represents 0.18% of its overall portfolio holdings.

Number of Shares
424
Previous 549 22.77%
Holding current value
$240,475
Previous $266,000 9.77%
% of portfolio
0.18%
Previous 0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 26, 2026

SELL
$524.58 - $588.02 $65,572 - $73,502
-125 Reduced 22.77%
424 $240,000
Q4 2024

Jan 28, 2025

SELL
$501.29 - $612.85 $12,532 - $15,321
-25 Reduced 4.36%
549 $285,000
Q3 2024

Nov 04, 2024

SELL
$531.86 - $624.21 $21,274 - $24,968
-40 Reduced 6.51%
574 $355,000
Q1 2024

May 02, 2024

SELL
$528.82 - $599.43 $26,441 - $29,971
-50 Reduced 7.53%
614 $356,000
Q3 2023

Nov 09, 2023

BUY
$498.29 - $574.41 $330,864 - $381,408
664 New
664 $336,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $222B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Slocum, Gordon & CO LLP Portfolio

Follow Slocum, Gordon & CO LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slocum, Gordon & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Slocum, Gordon & CO LLP with notifications on news.